Breaking the Cold Chain: ARPA-H Launches Ambitious $87 Million Initiative to Stabilize Cell-Based Medicines
The landscape of modern medicine is undergoing a profound transformation, shifting from small-molecule pharmaceuticals to living, cell-based therapies. However, this...
